CADTH is seeking nominations for its advisory and expert committees. If you have significant expertise in the Canadian health care system, are interested in helping support health care decision-makers in making informed choices about health technologies, and are passionate about ensuring that the…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH is pleased to announce a new collaboration with Health Canada and the Institut national d'excellence en santé et services sociaux (INESSS) in support of Health Canada’s Regulatory Reviews of Drugs and Devices initiative. Pharmaceutical companies can now receive early parallel scientific…
See Pharmaceutical Reviews Update — Issue 5 for important news and information regarding CADTH’s drug review programs. Highlights from this issue:
CADTH’s call for nominations for its Patient and Community Advisory Community
Webinar to learn about the upcoming consultation on the proposal to…
The CADTH Scientific Advice Program now offers a new level of responsiveness and flexibility to better meet the needs of the pharmaceutical industry. In the fast-paced and demanding environment of drug development, a one-size-fits-all approach simply isn’t optimal. Applicants may now inquire about…
CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer parallel scientific advice to pharmaceutical companies.
Through this new initiative, participating pharmaceutical companies will receive advice simultaneously from CADTH…
CADTH is currently seeking individuals with diverse experiences with the Canadian health care system for our Patient and Community Advisory Committee.
This newly established committee will provide CADTH with advice on issues relevant to CADTH’s mandate, from the perspectives of those using the…
A document related to the project entitled Optimal Use of Minimally Invasive Glaucoma Surgery: Recommendation is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Consultation Document
Product Type
Submit Stakeholder Feedback
Optimal Use of…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
See Pharmaceutical Reviews Update – Issue 4 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:
an upcoming webinar on the CADTH/pCODR clinician input and feedback process
an update on the transition of the Cancer Drug Implementation…
A document related to the project entitled Triple csDMARDs for Rheumatoid Arthritis is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Triple csDMARDs for Rheumatoid Arthritis
2018-12-12
2019-01-04
Consultation Document
Product Type
Submit…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.